327 related articles for article (PubMed ID: 15825716)
1. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
Uaratanawong S; Deesomchok U; Hiransuttikul N; Uaratanawong S
J Med Assoc Thai; 2004 Nov; 87(11):1374-9. PubMed ID: 15825716
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in premenopausal women with systemic lupus erythematosus.
Uaratanawong S; Deesomchoke U; Lertmaharit S; Uaratanawong S
J Rheumatol; 2003 Nov; 30(11):2365-8. PubMed ID: 14677178
[TBL] [Abstract][Full Text] [Related]
3. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
Kipen Y; Briganti E; Strauss B; Will R; Littlejohn G; Morand E
J Rheumatol; 1999 Feb; 26(2):310-7. PubMed ID: 9972964
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
5. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah S; Chow SK; Goh EM
Lupus; 2009 Feb; 18(2):178-81. PubMed ID: 19151123
[TBL] [Abstract][Full Text] [Related]
6. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.
Mok CC; Wong SN; Ma KM
Rheumatology (Oxford); 2012 Mar; 51(3):468-75. PubMed ID: 22096013
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
8. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.
Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Chadha AB; Ramsey-Goldman R
Rheumatology (Oxford); 2006 Jan; 45(1):53-60. PubMed ID: 16278288
[TBL] [Abstract][Full Text] [Related]
9. Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus.
Mok CC; To CH; Ma KM
Lupus; 2008 Nov; 17(11):1018-22. PubMed ID: 18852226
[TBL] [Abstract][Full Text] [Related]
10. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
Mok CC; To CH; Mak A; Ma KM
Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
[TBL] [Abstract][Full Text] [Related]
12. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
[TBL] [Abstract][Full Text] [Related]
13. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in women with sarcoidosis.
Sipahi S; Tuzun S; Ozaras R; Calis HT; Ozaras N; Tuzun F; Karayel T
J Bone Miner Metab; 2004; 22(1):48-52. PubMed ID: 14691687
[TBL] [Abstract][Full Text] [Related]
15. Development of bone mineral density at the lumbar spine and femoral neck in juvenile chronic arthritis--a prospective one year followup study.
Kotaniemi A; Savolainen A; Kröger H; Kautiainen H; Isomäki H
J Rheumatol; 1998 Dec; 25(12):2450-5. PubMed ID: 9858444
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
Legroux-Gerot I; Vignau J; Collier F; Cortet B
Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus.
Rhew EY; Lee C; Eksarko P; Dyer AR; Tily H; Spies S; Pope RM; Ramsey-Goldman R
J Rheumatol; 2008 Feb; 35(2):230-6. PubMed ID: 18203323
[TBL] [Abstract][Full Text] [Related]
18. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
19. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
Pastores GM; Elstein D; Hrebícek M; Zimran A
Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
[TBL] [Abstract][Full Text] [Related]
20. Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy.
Mease PJ; Ginzler EM; Gluck OS; Schiff M; Goldman A; Greenwald M; Cohen S; Egan R; Quarles BJ; Schwartz KE
J Rheumatol; 2005 Apr; 32(4):616-21. PubMed ID: 15801015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]